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The first decade of genome sequencing stimulated an explosion in the
characterization of unknown proteins. More recently, the pace of functional
discovery has slowed, leaving around 20% of the proteins even in
well-studied model organisms without informative descriptions of their
biological roles. Remarkably, many uncharacterized proteins are conserved
from yeasts to human, suggesting that they contribute to fundamental bio-
logical processes (BP). To fully understand biological systems in health
and disease, we need to account for every part of the system. Unstudied
proteins thus represent a collective blind spot that limits the progress of
both basic and applied biosciences. We use a simple yet powerful metric
based on Gene Ontology BP terms to define characterized and uncharacter-
ized proteins for human, budding yeast and fission yeast. We then identify a
set of conserved but unstudied proteins in S. pombe, and classify them based
on a combination of orthogonal attributes determined by large-scale exper-
imental and comparative methods. Finally, we explore possible reasons why
these proteins remain neglected, and propose courses of action to raise their
profile and thereby reap the benefits of completing the catalogue of proteins’
biological roles.1. Slow progress in characterizing unknowns
When the first eukaryotic chromosome (chromosome III of Saccharomyces cerevi-
siae) was sequenced in 1992, the most surprising discovery was that previously
undetected protein-coding genes outnumbered mapped genes by a factor of
five [1,2]. Researchers had generally assumed that few proteins remained to
be discovered, especially in an organism as intensively studied as yeast. The
completion of the S. cerevisiae genome sequence in 1996 confirmed that more
than half the genes lacked any indication of their biochemical activity or
broader biological role [2]. Over the ensuing two decades, complete genome
sequences have become available for over 6500 eukaryotic species [3]. At first,
characterization of newly discovered genes progressed rapidly in model
species, as researchers supplemented classical biochemistry and forward
genetics with reverse genetics, homology modelling and large-scale systematic
techniques to study novel genes. Complete genome sequences also allowed the
deployment of large-scale systematic techniques [4]. More recently, however,
progress has slowed, even in well-studied species such as the budding yeast
S. cerevisiae and the fission yeast Schizosaccharomyces pombe.
Figure 1 shows protein characterization over the past 28 years for these two
yeasts. Notably, the proportions characterized in fission yeast (84%) and
budding yeast (82%) have only slightly increased in the past decade (from
80%, as noted by Pen˜a-Castillo & Hughes [11], and 77%, respectively). Across
all studied eukaryotic species, the proportion of characterized proteins has
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Figure 1. Characterization history of budding yeast and fission yeast proteins.
Numbers of S. pombe and S. cerevisiae proteins that have had their biological
roles either determined from experiments or inferred from sequence orthol-
ogy to known proteins in other species, plotted as a function of time. The
numbers of unknown proteins have not markedly decreased over the past
15 years. Data sources: S. cerevisiae 1994–1998 [5], 2000 [6], 2002 [7],
2009 [8], 2013 [9], 2018 this study (figure 3); S. pombe [10].
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2reached a plateau around 80%, and exhibits a long-tailed
distribution, with the biological roles of the remaining 20%
still elusive.
Here, we use a simple yet powerful metric based on Gene
Ontology (GO) biological process (BP) terms to define charac-
terized and uncharacterized proteins for human and the two
model yeasts. We then combine our GO-based classification
with information about taxonomic conservation using fission
yeast to identify a set of broadly conserved, but unstudied,
proteins. We classify the fission yeast conserved but unstu-
died protein set based on a combination of orthogonal
attributes (e.g. taxonomic conservation, mutant viability,
protein sequence features, localization). Finally, we explore
possible reasons why these proteins remain neglected, pro-
pose courses of action to raise their profile among bench
researchers and bioinformaticians, and posit the benefits of
completing catalogue of proteins’ biological roles.2. Defining unknown metrics: what counts
as ‘known’?
To estimate more precisely the proportion of a proteome that
is characterized, and to provide inventories of uncharacter-
ized gene products, the ‘known’ category must be
rigorously defined. However, the gradual accumulation of
data of many different types, from diverse experimental
and computational methods and multiple sources, makes it
challenging to draw a clear line between ‘known’ and
‘unknown’. For example, in 2004 Hughes et al. [12] observed
that the then-current Yeast Proteome Database (YPD) listed
80% of S. cerevisiae genes as ‘known’, but also noted that by
more stringent criteria based on GO annotation then in the
Saccharomyces Genome Database (SGD), 30–40% remained
unknown and others only poorly understood. Knowledge
acquisition is necessarily a continuum—different experiments
are performed at different scales (e.g. high- versus low-
throughput) and yield results at different levels of biological
detail (e.g. detecting DNA repair versus distinguishingmismatch repair from base excision repair) and confidence
(stemming from variation in the quality of assays and the
number of replicates performed). For these reasons, the
characterization status of gene products does not fall on a
simple linear scale. Biologists often make qualitative judge-
ment calls to designate individual gene products as ‘novel’,
‘barely characterized’ or ‘relatively well characterized’.
While this serves the purposes of individual researchers
working on a gene-by-gene basis, a more quantitative and
objective approach is required to summarize the status of
functional characterization for an entire proteome, and to
facilitate cross-species comparisons.
2.1. Metrics to describe functional characterization
levels
To develop workable metrics for the status of the functional
annotation of a given proteome, we have exploited GO annota-
tion [13], and illustrate this scheme using the proteomes of S.
cerevisiae, S. pombe and human as examples. Since the functional
attributes of gene products of diverse species are routinely
described using GO, these metrics are widely applicable.
The GO molecular function (MF) ontology describes
molecular-level activities of gene products (such as catalytic,
transporter and receptor activities). GO BP refers to ordered
assemblies of MFs representing physiological roles of gene
products (e.g. involvement in cytokinesis or DNA replication).
GO cellular component (CC) provides the locations of gene
products (organelles, complexes, etc.). Determining each anno-
tation type relies on different experimental techniques,
yielding complementary results and insights. We might
know a gene product’s MF or its localization (CC), but not
the physiological context in which that product acts (BP).
2.2. Annotation coverage for proteins by Gene Ontology
aspect
One simple way to quantify the degree to which the function
of a given gene product has been characterized is to report
annotation to one, two or all three GO aspects (MF, BP,
CC). GO aspect coverage provides a simple metric that is
accessible for any species by counting gene products with
(or without) annotation to each aspect. Figure 2 shows cover-
age by ontology aspect for human, fission yeast and budding
yeast proteins. From this viewpoint, we can quickly assess the
number of gene products annotated to all three aspects of GO
(usually well characterized), or none at all (uncharacterized),
and assess what types are absent for a species.
2.3. Known physiological function: Gene Ontology slim
process coverage
Although informative, the activities captured by MF and the
localizations described byCCmake onlya limited contribution
to knowledge about a gene product’s characterization if taken
in isolation.Although someMF terms (such as thosedescribing
transcription factor activities, substrate-specific transmem-
brane transporter activities, and some specific catalytic
activities) implicitly refer to physiological roles, biologically
informative gene characterization usually requires additional
data to place the activity into a broader physiological context.
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Figure 2. GO aspect coverage of budding yeast, fission yeast and human
proteins. Venn diagrams indicate the number of protein coding gene products
annotated to each Gene Ontology aspect (biological process, molecular func-
tion, cellular component). Data sources: S. pombe, PomBase 25 September
2018; S. cerevisiae, YeastMine [14] 25 September 2018; human, HumanMine
[15] and GO repository [16], both 26 September 2018.
royalsocietypublishing.org/journal/rsob
Open
Biol.9:180241
3By contrast, BP annotation provides this context, and thereby
reveals more about the role of a gene product in an organism’s
biology, and provides a useful benchmark for preliminary
characterization. As an example, knowing that a protein is a
kinase (MF) is not very informative until we find that a del-
etion mutant of the gene encoding that protein is defective
inmeiotic nuclear division (BP) and the protein itself localizes
to chromatin (CC).
To use this information as a measure of the progress in a
protein’s functional characterization, we use the annotation
overviews provided by tailored GO term subsets known as
‘GO slims’ [17]. We created a BP slim set covering as many
annotated gene products as possible, while remaining infor-
mative about the physiological context in which they
operate. As our starting point, we took the fission yeast GOBP slim developed at PomBase over 8 years [18], which pro-
vides excellent coverage of informative cellular processes for
fission yeast (99.4% of annotated proteins with a known pro-
cess), and minimizes overlap between terms. The PomBase
slim aims to demonstrate the distribution of processes
within distinct ‘modules’ of biology (cytokinesis, tRNA
metabolism, DNA replication etc.) [19,20], and therefore
excludes overly general BP terms, such as ‘metabolism’ or
‘cellular component organization’, that would increase cover-
age at the expense of specific context. Terms that recapitulate
activities in the MF ontology (e.g. ‘protein phosphorylation’)
or describe phenotypic observations but do not correspond to
a specific physiological role for a gene product (e.g. ‘response
to chemical’) are also excluded. Following the same prin-
ciples, we extended the 53-term PomBase slim into a
generalized process slim of 117 terms to use in cross-species
analysis, as summarized in figure 3a.
For any annotation-based metric, it is important to dis-
tinguish unknown (or unstudied) from unannotated gene
products. Here, unknown gene products are defined as those
that have been evaluated by curators and have no annotation
to any BP slim terms (these gene products are annotated to
the root term ‘BP’ with the evidence code ‘no data (ND)’
[22,23]). Unannotated are those not explicitly indicated as
unknown but which, nevertheless, have no annotation from
experiment or inference. Because all fission yeast and bud-
ding yeast genes have been systematically assessed using all
available data, any gene products lacking specific GO anno-
tations can confidently be deemed to have unknown
biological roles. For the human proteome, manual inspection
of the unannotated proteins revealed that many can actually
be annotated to a BP based on experimental data in the litera-
ture or by homology-based inference, and thus classified as
characterized. To make this knowledge available, we manu-
ally curated 931 GO annotations for 502 human proteins
from 310 publications, including BP assignments for 238 pre-
viously unannotated proteins. These annotations will be
submitted to the Gene Ontology Consortium for inclusion
in the human GO annotation dataset. Figure 3b shows the
proportions of the S. pombe, S. cerevisiae and human pro-
teomes that are known (i.e. annotated to informative BP
terms), unannotated, annotable, or unknown. See electronic sup-
plementary material data for GO slim term IDs (electronic
supplementary material, table S1), input protein lists (elec-
tronic supplementary material, tables S2–S4), GO slim
outputs (electronic supplementary material, tables S5–S7),
unknown gene lists (electronic supplementary material,
tables S8–S10), GO terms considered for the slim but not
included (electronic supplementary material, table S11) and
human GO annotations generated by this study (electronic
supplementary material, table S12).3. Why do these proteins remain
unstudied?
Our GO slim-based characterization metric confirms the
impression from simpler metrics that, for the two model
yeasts and human, about 20% of proteins lack physiologically
informative descriptions. Why do so many proteins, many of
them conserved, remain unstudied? Below, we consider bio-
logical and sociological/cultural factors that contribute to the
apparent lack of interest in these unknown proteins.
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Figure 3. GO slim analysis of budding yeast, fission yeast and human proteins. (a) Generic GO biological process slim set creation flowchart. The fission yeast GO
biological process slim [18] was applied to human and S. cerevisiae protein sets, and then iteratively extended to improve coverage by adding terms. All evidence
codes were included except ‘reviewed computational analysis’ (RCA), which yields a higher rate of false positives than the others. Some processes were swapped (e.g.
‘cytoplasmic translation’ in the fission yeast slim for more general ‘translation’) to accommodate the less specific annotation available in other species. The fission
yeast slim also omits overly broad terms (e.g. ‘metabolism’) and terms representing activities (molecular functions) in the biological process ontology (e.g. ‘phos-
phorylation’) because they do not add information about physiological roles; these terms were also excluded from our generic slim set even if inclusion would have
increased coverage. (Terms specifically considered but omitted from the generic slim are listed in electronic supplementary material, table S11). At convergence (the
point where no additional informative terms could be identified for gene products with biological process annotations), proteins annotated to slim terms were
classified as ‘known’ (4393 S. pombe; 4936 S. cerevisiae; 16354 human). The remaining proteins with uninformative processes were classified as unknown,
along with those already identified as unknown by annotation to the root node with evidence code ND (no data). Manual assessment of the remaining
human proteins with no GO biological process annotation added 266 proteins, bringing the ‘known’ total to 16620. Final ‘unknown’ protein totals are 676 in
S. pombe, 978 in S. cerevisiae and 3117 in human. The set of GO slim terms is available in electronic supplementary material, table S1. (b) Proportions of proteins
with known GO slim biological role. For all three species, ‘known’ proteins have annotation to at least one term from the GO slim set (see A), and ‘unknown’ proteins
do not. Because the human proteome includes some proteins that lack annotation in the GO database, the proportions of unannotated proteins that we found to be
known (i.e. annotatable) and unknown are indicated separately. All protein datasets exclude dubious proteins and transposons. Analysis was performed using
GOTERMFINDER [21], with GO data from 25 September 2018 and the GO slim created as described in A. Input protein lists are available in electronic supplementary
materials, tables S2 (S. pombe), S3 (S. cerevisiae) and S4 (human). GOTERMFINDER output is available in electronic supplementary material, tables S5 (S. pombe), S6
(S. cerevisiae) and S7 (human).
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43.1. Biological bias
One factor influencing gene characterization is simply how
easily one gene’s contribution to an organism can be
detected. Deletion mutants of essential genes have a clear
phenotype that indicates an important function—for yeasts,
the failure to grow on rich media. As a consequence, these
genes, and the core processes in which they participate, are
well characterized. For example, only 24 of the genes in the
fission yeast unknown set are essential in rich media.
Changes in cell morphology are also readily identifiable phe-
notypes. Visual screening and analysis of the fission yeast
genome-wide deletion collection for morphology phenotypes
under standard laboratory conditions found obvious
abnormalities for only 10% of 643 genes of unknown function
[24]. The most commonly used experimental conditions,
designed as they are to maximize cell growth, can hide
environment-dependent roles. Many more of the 676
currently uncharacterized (per figure 3b) fission yeast genes
are associated with growth or viability phenotypes upon
specific chemical challenges (26.1%) than under standardlaboratory conditions (3.6%) (PomBase [19,20], queries run
11 November 2018). In budding yeast, only 34% of all del-
etion mutants display a growth phenotype under standard
laboratory conditions, whereas 97% of all genes are essential
for optimal growth in at least one condition when assayed
under multiple chemical or environmental perturbations [25].
Protein characterization has traditionally emphasized core
BP over those that reflect interactions with the environment.
However, analysis of the proteins that have recently
(2016–2018) been removed from the fission yeast ‘conserved
unknown’ set because their functions have been determined
reveals that they most often participate in environment-
responsive processes such as signalling, detoxification,
proteostasis, lipostasis and mitochondrial organization
(table 1). Many of these functions are associated with the
age-related accumulation of damaged or misfolded proteins,
which become debilitating over time. In humans, such func-
tions are implicated in neurodegenerative diseases, such as
Alzheimer’s and motor neuron diseases [26], which under-
scores the importance of making strenuous efforts to
elucidate the functions of the remaining ‘conserved
Table 1. GO slim classiﬁcation of conserved S. pombe proteins characterized
between 2016 and 2018.
process proteins
membrane biology
lipid metabolism 15
transmembrane transport 9
vesicle-mediated transport 9
organelle localization by membrane tethering 4
other membrane organization 3
other ER processes 2
42
communication
signaling 9
transcription 6
chromatin organization 1
16
catabolism and detoxiﬁcation
detoxiﬁcation 25
protein catabolism 5
apoptotic process 4
DNA repair 3
nucleobase-containing compound catabolism 5
autophagy 1
mannose catabolism 1
44
mitochondrial processes and energy
mitochondrial gene expression 4
mitochondrial organization 3
energy generation 4
11
other processes
tRNA metabolism (cytosolic) 3
ribosome biogenesis (cytosolic) 5
mRNA metabolism 2
cytoplasmic translation 2
cytoskeleton organization 3
protein folding (cytosolic) 1
protein complex assembly 1
nucleocytoplasmic transport 1
chromosome segregation 1
amino acid metabolism 2
cofactor metabolism 1
other 5
27
total 140
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5unknowns’. It should also be pointed out that the ecology of
yeasts is poorly understood, and we postulate that many
unknown proteins function in aspects of life that are not nor-
mally probed in the laboratory (e.g. interactions withpathogens, or survival within insect vectors). We anticipate
that a greater variety of experimental conditions will
supply more information about the unknown gene products
catalogued here to reveal the roles of many gene products in
processes fundamental for human health.
3.2. Research bias
In fission yeast, the majority of new knowledge over the past
decade provides increasing detail for previously described
proteins. This bias towards studying already-known proteins
is not peculiar to yeast research. In their essay ‘Too many
roads not taken’ [27], Edwards et al. observe that 70% of
human protein research still focuses on the 10% of proteins
known before the human genome was sequenced. Although
few studies have explored the causes of the observed empha-
sis on known proteins, we can identify a number of plausible
contributing factors, which are largely borne out by a recent
large-scale analysis of publications on human genes [28].
First, the complexity of biology demands that investigators
narrow their study targets to a manageable range. Research-
ers with established interests in specific topics thus naturally
focus their work where they have deep knowledge, and
extend their studies to novel genes only if a strong lead
emerges, for instance, from work in another species or from
a data-mining approach that implicates them in BP already
under investigation. Indeed, Stoeger et al. [28] find that
research in model organisms strongly influences the initial
study of individual human genes. Both papers also highlight
pragmatic considerations, notably the availability of research
tools, and socio-political factors including career timelines,
funding priorities, and peer review, all of which exacerbate
the tendency to avoid the wholly unknown. Risk-averse fun-
ders and reviewers tend not to favour long-range strategies
aimed at genes without an existing functional context for
fear of diverting resources towards targets whose significance
is not guaranteed. Without a shift in perspective, proteins
without any existing functional annotation will continue to
be neglected, to the detriment of basic and applied biome-
dical research. Stoeger et al. [28] note that current research
is not only slow to cover novel genes but also ‘can signifi-
cantly deviate from the actual biological importance of
individual genes’.4. Classifying the conserved unknown
proteins, or: what lies undiscovered?
The stubborn core of remaining proteins of unknown func-
tion are often dismissed as species-specific, but we have
often found otherwise, and we can no longer afford to
sweep these proteins under the carpet. Therefore, to provide
further insight into why some gene products elude physio-
logical characterization, we present a case study using the
set of 410 fission yeast proteins of unknown physiological
role that have orthologues outside the Schizosaccharomyces
clade (the ‘conserved unknowns’). We classify these 410 pro-
teins according to a range of orthogonal biological attributes
(including taxonomic conservation, identification of a cataly-
tic fold or domain, cellular localization, viability). Figure 4
presents the subset of 200 proteins in this group which are
conserved outside fungi (in vertebrates, archaea or bacteria;
details for the full set of 410 proteins are provided in
410
fission yeast
conserved
unknown
proteins
fungi
only 165
metazoa
(to human)  165
46 
bacteria and 
archaea  (AC)  84 
mixed 
species
AC and
metazoa  32 
20 40 60 80 100 120 140 160 180 200
proteins
taxonomic
conservation
S. cerevisiae absent
localization
catalytic activity
non-catalytic
membrane
essentiality
metazoa 147(AC and metazoa 32)
bacteria and archaea (AC) 84
nucleus 28 nucleus 18 nucleus 58
DUF 19
Mt. 17 ER 17 Cyt, PM, Unk 23
essentiality taxonomic conservation localization catalytic activily non-catalytic domain membrane
essential
non-essential
bacteria and archaea, ancient conserved (AC)
vertebrate (human)
fungi
fungi only
absent from S.cereviside
mixed species (other)
nucleus transferase
oxidoreductase
hydrolase
isomerase/cyclase/lyase
unknown
no domain
misc
other binding (metal ion, lipid)
nucleic acid binding
domain of unknown function (DUF)
predicted TMMsprotein interaction (PI) domain WD/TPR/ANK/LRR/WW/SEL1/BRCT/Kelch
nucleolus
mitochondria (Mt.)
ER/Golgi (ER)
cytoplasm (Cyt), plasma membrane (PM), unknown (Unk)
cell surface
no data
Figure 4. Taxonomic conservation and features of unknown proteins. Classification of 210 conserved unknown fission yeast proteins along various axes. PomBase
curators manually assign protein-coding genes to one of a set of broad taxonomic classifiers [20,29]. PomBase also maintains manually curated lists of orthologues
between S. pombe and S. cerevisiae, and between S. pombe and human, three eukaryotic species separated by approximately 500–1000 million years of evolution.
In combination, these inventories can be used to identify conservation across taxonomic space at different levels of specificity. Of the fission yeast ‘unknown’ protein-
coding genes, 410 are conserved outside the Schizosaccharomyces clade. Of these, 210 are present either in fungi and vertebrates, or in fungi and prokaryotes (data
from PomBase manual assignments, queried on 31 July 2018). Proteins were classed as catalytic (i.e. having an identifiable catalytic fold) or non-catalytic (no
currently identifiable catalytic fold) based on protein domain, fold, clan or superfamily membership, using InterPro [30] and GO [13] assignments. Cellular locations
using GO annotation are available for most of the unknown proteome based on a genome-wide localization study and inference from other models [31]. Viability
data come from large-scale screens reported by Kim et al. [32] and Chen et al. [33]. The fission yeast ‘conserved unknown’ protein set [18] is reviewed continually
for new functional data.
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6electronic supplementary material, figure S1 and table S13).
The number of conserved unknown proteins that play an
essential role under permissive growth conditions is dispro-
portionally low (4.4%; 18/410, versus 1278/4376 (29.2%)
known, inferred or published), and almost half of these 18
essential proteins are localized to the mitochondria or the
endoplasmic reticulum. Only 8 essential genes are conserved
in vertebrates (all are organellar), and only a single protein
out of 53 conserved between yeast and prokaryotes (but not
vertebrates) is essential. A substantial proportion of the 200
proteins conserved outside the fungi (76) are absent from
Saccharomyces due to the well-documented lineage-specific
gene losses in its evolutionary history [34]; characterized
gene products with this taxonomic distribution are most
highly enriched for chromatin organization and mRNA
metabolism. Unknown mitochondrial and endomembrane
system proteins are enriched for proteins with transmem-
brane domains (59/114). Unknown nuclear proteins are
predicted to include more transferases than other enzymatic
activities; the set of nuclear proteins shared only with eukar-
yotes includes 19 domains of unknown function (DUFs) withno currently identifiable catalytic domain, and 12 protein–
protein interaction domains (e.g. WD, ankyrin or TPR) that
frequently function as scaffolds for protein complexes [30].
This multi-factorial classification can support the prediction
of likely physiological roles that can be experimentally tested.5. Strategies to link unknown genes to
broad cellular roles
Despite almost a century of gene product-specific biochemi-
cal and genetic interrogation, and two decades of post-
genomic research, a large number of proteins conserved
from yeast to human still have no known biological role.
Broadly conserved unknown eukaryotic proteins can be
assumed to have important cellular roles conserved over
500 million years of evolution. It is, therefore, remarkable
that this gene set has hardly reduced over the past decade.
In this period, familiar genes have been studied in
ever-greater depth, presumably at the expense of the charac-
terization of genes of hitherto unknown function (e.g. over
royalsocietypublishing.org/journal/rsob
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733 000 papers with ‘p53’ in the title have been published since
2007). Assuming a diminishing return for studies on highly
characterized proteins, investigations on unstudied proteins
will have a relatively higher impact that is likely to outweigh
the considerable initial efforts required to place them within
the context of current knowledge.
To jump-start renewed progress in unknown gene charac-
terization, two major stumbling blocks must be overcome.
One is to identify the cohort of genes of unknown function,
and the other is to develop mechanisms to bring the proteins
that they encode to the attention of interested researchers.
Here, we provide a framework that uses a generally accessi-
ble set of criteria based on manually curated data to
identify and classify unstudied proteins, which could easily
be extended with additional criteria for further annotation
specificity in future iterations. The construction of inventories
of unknown proteins will ultimately depend on accurate and
complete functional annotation of all genes of the major
model species.
Commentators on genome-scale research have long recog-
nized that, in order to fully describe an organism’s protein
complement, it will be necessary to deploy parallel exper-
imental and computational methods, at both large and
small scales [4,12]. Understanding how investigatory biases
and the characteristics of particular gene sets have convergedto prevent characterization will help us to identify the most
promising routes to uncovering unknown functions. These,
and other factors that contribute to the neglect of the charac-
terization of conserved gene products that are likely to have
novel biological roles, deserve further in-depth consideration.
It is likely that, to fill the persistent knowledge gaps rep-
resented by the roughly 20% of proteins that remain
uncharacterized, a creative combination of existing and emer-
ging experimental and in silico methods will be required, as
well as an increased awareness among the scientific commu-
nity of the value of a full proteome description. Because basic
knowledge at the cellular level provides the building blocks
of translational research, drug discovery, personalized medi-
cine, metabolomics and systems biology, comprehensive
proteome characterization underpins the success of numer-
ous and diverse endeavours across all of the biological and
medical sciences.
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